Paclitaxel treatment regimen for metastatic melanoma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 31, 2002
app pub date -
Apr 18, 2001
filing date -
Apr 18, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates generally to a method of using paclitaxel in a specific Q4D.times.3 schedule and dosage for patients with malignant melanoma. The low risk-benefit ratio of this specific schedule provides a method for therapeutic use for all stages of severity of disease ranging from local resectable tumor to diagnosed widespread malignant melanoma.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully